| http://www.w3.org/ns/prov#value | - The Tenen laboratory has now identified mutations and specific abnormalities in expression and function of C/EBP alpha and PU.1 in specific subtypes of myeloid leukemias, and a major effort in our laboratory is now focused on further characterization of the role of C/EBP alpha and PU.1 in leukemogenesis, as well as developing drugs and other therapies specifically aimed at C/EBP alpha and PU.1.
|
